Ironwood Pharmaceuticals (IRWD) Financials: Revenue & Earnings

IRWD price $3.56 +0.06 +1.57%

Ticker
IRWD
Price
$3.56
Change
+0.06 +1.57%
Market cap ?
$589.08M
P/E ?
4.35
Forward P/E ?
2.91
Dividend yield ?
0.00%
Beta ?
0.22
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Financials

2016201720182019202020212022202320242025
273957000298276000346639000428413000389523000413753000410596000442735000351410000296151000

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic…

Fair value

IRWD fair value $36.04. Price $3.56. Price is 90% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 85% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 185.55M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 165.24M. Net debt 382.35M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare IRWD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—0.32—119.99M
2026-08-060.310.32113.04M114.84M
2026-05-070.240.07106.51M92.11M
2026-02-25-0.010.0247.71M50.92M
2025-11-100.240.09122.06M74.71M
2025-08-070.14-0.0285.24M60.77M
2025-05-07-0.23-0.0541.14M45.90M
2025-02-270.020.1290.55M93.77M
2024-11-070.020.0891.59M91.22M
2024-08-08-0.010.1594.40M107.10M
2024-05-09-0.020.1974.88M105.75M
2024-02-15-0.010.21117.55M117.47M
2023-11-090.090.16113.74M114.00M
2023-08-080.310.25107.38M103.70M
2023-05-040.250.24104.06M100.35M
2023-02-160.270.27107.20M108.04M
2022-11-030.280.27108.64M109.15M
2022-08-040.210.3097.23M103.55M
2022-05-050.210.2697.53M96.62M
2022-02-170.270.31117.13M110.17M
2021-11-040.330.31103.75M106.42M
2021-08-050.340.23104.03M104.03M
2021-05-060.240.2188.84M90.17M
2021-02-170.360.29116.68M111.95M
2020-11-050.230.15103.47M67.48M
2020-08-060.160.0989.43M73.78M
2020-05-060.040.0579.94M99.93M
2020-02-130.300.24126.30M101.04M
2019-10-310.400.11131.17M36.07M
2019-07-300.10-0.03102.22M30.66M
2019-05-02-0.26-0.1468.73M54.68M
2019-02-13-0.02-0.15130.69M980.19M
2018-11-06-0.38-0.1765.69M57.38M
2018-08-06-0.28-0.2181.11M60.83M
2018-05-01-0.27-0.2369.16M58.95M
2018-02-15-0.14-0.1894.21M121.11M
2017-11-02-0.18-0.2286.83M106.09M
2017-08-03-0.30-0.2265.08M51.15M
2017-05-08-0.36-0.2052.17M45.19M
2017-02-21-0.09-0.2487.46M233.33M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-15DENNER ALEXANDER JBuy3.69K——
2026-07-20Silber JeffreyBuy137.04K——
2026-07-20Silber JeffreyOther0——
2026-07-07Silver RonaldSell127.89K$4.52578.06K
2026-06-16Shepard JayBuy63.48K——
2026-06-16Kessler Marla LBuy63.48K——
2026-06-16Currie Mark GBuy63.48K——
2026-06-16Duane Jon RBuy63.48K——
2026-06-16DENNER ALEXANDER JBuy63.48K——
2026-06-16McHugh JulieBuy63.48K——
2026-06-16McHugh JulieSell21.57K$3.7380.46K
2026-06-16Moukheibir CatherineBuy63.48K——
2026-06-15DENNER ALEXANDER JBuy4.07K——
2026-05-19Silver RonaldBuy25.00K——
2026-03-17DENNER ALEXANDER JSell6.72M$3.0520.51M
2026-03-17DENNER ALEXANDER JSell5.80K$3.3119.20K
2026-03-13DENNER ALEXANDER JBuy4.45K——
2026-03-10John MinardoBuy136.61K——
2026-03-10Martini Gregory S.Buy136.61K——
2026-03-10Gaskins Tammi LBuy136.61K——
2026-03-10Shetzline MichaelBuy136.61K——
2026-03-10Silver RonaldBuy163.93K——
2026-03-10MCCOURT Thomas ABuy409.84K——
2026-02-24John MinardoSell19.05K$3.6669.73K
2026-02-24Shetzline MichaelBuy17.01K$3.6662.26K
2026-02-24Gaskins Tammi LSell11.24K$3.6641.13K
2026-02-24MCCOURT Thomas ASell103.53K$3.66378.91K
2026-02-24Martini Gregory S.Sell11.46K$3.6641.93K
2026-02-24Silver RonaldSell12.62K$3.6646.19K
2026-02-23John MinardoSell17.44K$3.8166.44K
2026-02-23Shetzline MichaelSell15.57K$3.8159.32K
2026-02-23Gaskins Tammi LSell10.29K$3.8139.19K
2026-02-23MCCOURT Thomas ASell94.76K$3.81361.02K
2026-02-23Martini Gregory S.Sell10.49K$3.8139.96K
2026-02-23Silver RonaldSell11.55K$3.8144.01K
2026-01-05Silver RonaldSell35.42K$4.60162.91K
2025-12-15DENNER ALEXANDER JBuy4.18K——
2025-11-17Gaskins Tammi LSell6.02K$3.3219.97K
2025-09-15DENNER ALEXANDER JBuy11.72K——
2025-08-11Gaskins Tammi LSell1.32K$0.841.11K
2025-08-11John MinardoSell7.75K$0.846.51K
2025-08-11Martini Gregory S.Sell1.26K$0.841.06K
2025-08-11Silver RonaldSell2.85K$0.842.39K
2025-06-13DENNER ALEXANDER JBuy24.19K——
2025-06-10Kessler Marla LBuy45.00K——
2025-06-10Shepard JayBuy45.00K——
2025-06-10Moukheibir CatherineBuy45.00K——
2025-06-10Duane Jon RBuy45.00K——
2025-06-10Currie Mark GBuy45.00K——
2025-06-10McHugh JulieBuy45.00K——
2025-06-10Dreyfus AndrewBuy45.00K——
2025-06-10DENNER ALEXANDER JBuy45.00K——
2025-05-20MCCOURT Thomas ABuy540.00K——
2025-05-16MCCOURT Thomas ASell13.35K$0.587.74K
2025-05-16Gaskins Tammi LSell2.56K$0.581.49K
2025-04-02DENNER ALEXANDER JBuy10.42K——
2025-03-11Gaskins Tammi LOther0——
2025-02-10MCCOURT Thomas ASell139.06K$1.76244.75K
2025-02-10Silver RonaldSell12.05K$1.7621.20K
2025-02-10Shetzline MichaelBuy133.33K——
2025-02-10Shetzline MichaelSell41.27K$1.7672.63K
2025-02-10John MinardoBuy122.22K——
2025-02-10John MinardoSell38.94K$1.7668.53K
2025-02-10Martini Gregory S.Sell12.05K$1.7621.21K
2025-01-27Silver RonaldBuy133.33K——
2025-01-27Martini Gregory S.Buy111.11K——
2025-01-27Martini Gregory S.Other0——
2025-01-27Martini Gregory S.Other3.31K$16.9055.89K
2025-01-27Martini Gregory S.Other1.59K$12.9520.55K
2025-01-17Shetzline MichaelBuy48.22K——
2025-01-17John MinardoBuy40.19K——
2025-01-17MCCOURT Thomas ABuy147.35K——
2024-12-16DENNER ALEXANDER JBuy4.25K——
2024-11-18Davis AndrewSell5.36K$4.0821.87K
2024-11-18Emany Sravan KumarSell11.00K$4.0844.88K
2024-09-16DENNER ALEXANDER JBuy3.28K——
2024-08-12John MinardoSell9.91K$4.2742.32K
2024-08-12Silver RonaldSell3.11K$4.2713.27K
2024-06-18Shepard JayBuy24.31K——
2024-06-18Dreyfus AndrewBuy24.31K——
2024-06-18Duane Jon RBuy24.31K——
2024-06-18McHugh JulieBuy24.31K——
2024-06-18Moukheibir CatherineBuy24.31K——
2024-06-18Kessler Marla LBuy24.31K——
2024-06-18DENNER ALEXANDER JBuy24.31K——
2024-06-18Currie Mark GBuy24.31K——
2024-06-15DENNER ALEXANDER JBuy2.57K——
2024-06-10McHugh JulieSell22.77K$6.29143.20K
2024-06-07Moukheibir CatherineSell35.57K$6.61235.14K
2024-06-06Moukheibir CatherineSell44.43K$6.36282.55K
2024-05-20MCCOURT Thomas ASell67.62K$6.45436.14K
2024-05-20Davis AndrewSell22.73K$6.45146.58K
2024-05-20Shetzline MichaelSell16.13K$6.45104.03K
2024-05-20John MinardoSell17.40K$6.45112.26K
2024-05-16Emany Sravan KumarSell18.28K$6.64121.38K
2024-03-15DENNER ALEXANDER JBuy1.66K——
2024-03-08John MinardoBuy32.75K——
2024-03-08John MinardoSell32.75K——
2024-03-08Emany Sravan KumarBuy37.12K——
2024-03-08Emany Sravan KumarSell37.12K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 220, holders -15 vs prior quarter. Ownership 99.03%.

HolderSharesChangeChange %Value
BLACKROCK, INC.17.79M4.43M+33.12%74.89M
ARMISTICE CAPITAL, LLC13.93M-1.10M-7.29%58.65M
SARISSA CAPITAL MANAGEMENT LP9.19M00.00%38.68M
STATE STREET CORP8.81M1.35M+18.14%37.09M
BANK OF AMERICA CORP /DE/8.68M896+0.01%36.56M
RENAISSANCE TECHNOLOGIES LLC7.99M-67.85K-0.84%33.65M
VANGUARD CAPITAL MANAGEMENT LLC6.61M511.05K+8.38%27.82M
AQR CAPITAL MANAGEMENT LLC6.47M-1.07M-14.19%27.22M
ACADIAN ASSET MANAGEMENT LLC5.85M-723.94K-11.01%24.62M
VANGUARD PORTFOLIO MANAGEMENT LLC5.51M-1.17M-17.49%23.21M
GEODE CAPITAL MANAGEMENT, LLC4.83M288.13K+6.34%20.35M
TWO SIGMA INVESTMENTS, LP4.56M-1.29M-22.10%19.18M
MARSHALL WACE, LLP4.29M-234.97K-5.19%18.06M
JACOBS LEVY EQUITY MANAGEMENT, INC4.07M433.49K+11.93%17.12M
GOLDMAN SACHS GROUP INC3.31M623.17K+23.16%13.95M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC3.30M-1.44M-30.30%13.90M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.3.30M3.30MNew13.90M
FEDERATED HERMES, INC.3.23M-117.57K-3.51%13.60M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP3.02M-380.15K-11.19%12.70M
DIMENSIONAL FUND ADVISORS LP2.52M440.84K+21.17%10.62M
MACKENZIE FINANCIAL CORP2.37M1.81M+322.74%9.97M
MORGAN STANLEY1.86M1.04M+125.49%7.83M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.1.81M-23.71K-1.29%7.63M
NORTHERN TRUST CORP1.37M108.13K+8.54%5.78M
HILLSDALE INVESTMENT MANAGEMENT INC.1.25M13.80K+1.12%5.26M

Earnings and financials

Ironwood Pharmaceuticals, Inc. (IRWD) trades at $3.56, with a market cap of $589.08M and a trailing P/E of 4.35. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
273957000298276000346639000428413000389523000413753000410596000442735000351410000296151000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Ironwood Pharmaceuticals (IRWD) Financials: Revenue & Earnings

IRWD$3.56+0.06 +1.57%

$589.08M

Market Cap

4.35

P/E

2.91

Forward P/E

—

Score

Price History